Insight Molecular Diagnostics Inc. (IMDX)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

12 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014
Revenue$4.1M$1.9M$1.5M$958,000$2.2M$1.2M
Gross profit$2.3M$740,000$413,000−$18,000$1.4M−$639,000
Research & development$15.9M$9.8M$9.3M$7.3M$5.0M$9.8M$6.8M$6.5M$7.2M$5.7M$4.5M$4.0M
Operating expenses$53.4M$61.8M$25.5M$18.0M$55.1M$29.1M$22.2M$15.2M$18.8M$11.1M$8.7M$5.0M
Operating income−$51.1M−$61.0M−$25.1M−$18.0M−$53.7M−$29.7M−$22.2M−$15.2M−$18.8M−$11.1M−$8.7M−$5.0M
EBITDAderived−$48.9M−$59.5M−$23.5M−$16.5M−$52.9M−$29.4M−$14.6M−$18.3M−$10.8M−$8.4M−$4.7M
Net income−$50.2M−$60.7M−$27.8M−$72.9M−$64.1M−$29.9M−$22.4M−$15.8M−$19.4M−$11.2M−$8.7M−$5.0M
Basic EPSper diluted share-$1.65-$4.66-$3.75-$13.25-$0.72-$0.46-$0.44-$0.42-$0.64-$0.42-$0.42-$0.27
Diluted EPSper diluted share-$1.65-$4.66-$3.75-$13.25-$0.72-$0.46-$0.44-$0.42-$0.64-$0.42-$0.42-$0.27

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys33$22.97M disclosed value
Sells (SEC code S)0$0.00 disclosed value
33 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 27, 2026Form 4BROADWOOD PARTNERS, L.P. +2TenPercentOwnerBuyCommon Stock, no par value · indirect0$0.00$0.0012.68M
Apr 27, 2026Form 4BROADWOOD PARTNERS, L.P. +2TenPercentOwnerBuyCommon Stock, no par value250.9K$3.64$913.4K12.68M
Apr 24, 2026Form 4BROADWOOD PARTNERS, L.P. +2TenPercentOwnerBuyCommon Stock, no par value · indirect0$0.00$0.0012.43M
Apr 24, 2026Form 4BROADWOOD PARTNERS, L.P. +2TenPercentOwnerBuyCommon Stock, no par value38.9K$3.53$137.2K12.43M
Apr 23, 2026Form 4BROADWOOD PARTNERS, L.P. +2TenPercentOwnerBuyCommon Stock, no par value · indirect0$0.00$0.0012.40M